"breast tumor subtypes" trang 7 - tải miễn phí từ tailieunhanh
Less micrometastatic risk related to circulating tumor cells after endoscopic breast cancer surgery compared to open surgery

Less micrometastatic risk related to circulating tumor cells after endoscopic breast cancer surgery compared to open surgery
9    72    0
BC200 overexpression contributes to luminal and triple negative breast cancer pathogenesis

BC200 overexpression contributes to luminal and triple negative breast cancer pathogenesis
17    78    0
Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer

Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer
8    103    0
Can apparent diffusion coefficient (ADC) distinguish breast cancer from benign breast findings? A meta-analysis based on 13 847 lesions

Can apparent diffusion coefficient (ADC) distinguish breast cancer from benign breast findings? A meta-analysis based on 13 847 lesions
14    70    0
External quality assessment (EQA) program for the immunohistochemical detection of ER, PR and Ki-67 in breast cancer: Results of an interlaboratory reproducibility ring study in China

External quality assessment (EQA) program for the immunohistochemical detection of ER, PR and Ki-67 in breast cancer: Results of an interlaboratory reproducibility ring study in China
9    66    0
Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan

Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan
11    55    1
Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients

Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients
8    56    1
The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC)

The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC)
8    85    1
Epoxyazadiradione suppresses breast tumor growth through mitochondrial depolarization and caspase-dependent apoptosis by targeting PI3K/Akt pathway

Epoxyazadiradione suppresses breast tumor growth through mitochondrial depolarization and caspase-dependent apoptosis by targeting PI3K/Akt pathway
17    69    1
Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer

Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer
8    61    1
Obesity and breast cancer outcomes in chemotherapy patients in New Zealand – a population-based cohort study

Obesity and breast cancer outcomes in chemotherapy patients in New Zealand – a population-based cohort study
13    51    1
Shifting breast cancer surveillance from current hospital setting to a community based setting: A cost-effectiveness study

Shifting breast cancer surveillance from current hospital setting to a community based setting: A cost-effectiveness study
10    72    1
Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality

Longitudinal autoantibody responses against tumor-associated antigens decrease in breast cancer patients according to treatment modality
9    36    1
Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history

Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triple-negative breast cancer without family cancer history
6    65    1
It is no longer the time to disregard thyroid metastases from breast cancer: A case report and review of the literature

It is no longer the time to disregard thyroid metastases from breast cancer: A case report and review of the literature
8    29    1
Pregnancy-associated breast cancer in rural Rwanda: The experience of the Butaro Cancer Center of Excellence

Pregnancy-associated breast cancer in rural Rwanda: The experience of the Butaro Cancer Center of Excellence
8    39    1
Phase II trial of eribulin mesylate as a firstor second-line treatment for locally advanced or metastatic breast cancer: A multicenter, single-arm trial

Phase II trial of eribulin mesylate as a firstor second-line treatment for locally advanced or metastatic breast cancer: A multicenter, single-arm trial
7    52    1
Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: A retrospective study

Efficacy and safety of eribulin in patients with locally advanced or metastatic breast cancer not meeting trial eligibility criteria: A retrospective study
7    77    1
Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133+ /EpCAM+ phenotype: A promising target for preventing progression of TNBC

Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133+ /EpCAM+ phenotype: A promising target for preventing progression of TNBC
11    54    1
BRCA2 carriers with male breast cancer show elevated tumour methylation

BRCA2 carriers with male breast cancer show elevated tumour methylation
11    82    1